These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Niflumic acid in maxillofacial injuries and in sequela of surgical interventions in O.R.L]. Decroix G; Pilliaert JM Lille Med; 1972 Feb; 17():Suppl 2:156-9. PubMed ID: 5034394 [No Abstract] [Full Text] [Related]
3. [Value of niflumic acid in otorhinolaryngology]. Portmann M; Pardes P Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):494-8. PubMed ID: 5715347 [No Abstract] [Full Text] [Related]
4. [Use of an anti-inflammatory agent, well tolerated by children, in the O.R.L. surgery]. Morgon AH; Dubreuil C J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 Jun; 27(6):419-22. PubMed ID: 151729 [No Abstract] [Full Text] [Related]
5. [Calcium bucloxate: its use in ORL inflammatory pathology]. Gaillard J; Dumolard P JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Feb; 24(2):153-5. PubMed ID: 123947 [No Abstract] [Full Text] [Related]
6. [The use of niflumic acid (Actol) in surgery. Report on 100 cases]. Klepp G; Rigler B Ther Ggw; 1973 May; 112(5):810 passim. PubMed ID: 4708584 [No Abstract] [Full Text] [Related]
7. [Preliminary study of the therapeutic action and tolerance of niflumic acid in pediatric otorhinolaryngology]. Traissac L; Roche JC Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):317-21. PubMed ID: 897412 [No Abstract] [Full Text] [Related]
8. [Results and considerations in the use of an anti-inflammatory and analgesic preparation in otorhinolaryngology]. Girardi G Minerva Med; 1967 Apr; 58(32):1487-9. PubMed ID: 6029515 [No Abstract] [Full Text] [Related]
10. [Niflumic acid (UP 83) in otorhinolaryngology. Clincal study of 75 cases]. Bouche J; Bruker J Ann Otolaryngol Chir Cervicofac; 1968 Jun; 85(4):361-8. PubMed ID: 5706080 [No Abstract] [Full Text] [Related]
11. [Advantages of a painless and colorless topical agent in otorhinolaryngology]. Appaix A; Dinand F; Houel B Mars Med; 1971; 108(1):79-81. PubMed ID: 4323276 [No Abstract] [Full Text] [Related]
12. [Use of a new antalgic anti-inflammatory agent in otorhinolaryngology]. Portmann M; Pardes P Rev Laryngol Otol Rhinol (Bord); 1971; 92(3):235-8. PubMed ID: 5565287 [No Abstract] [Full Text] [Related]
13. [The beta-morpholino ethyl ester of niflumic acid in the treatment of orchi-epididymitis]. Mazeman E; Biserte J Lille Med; 1980 Nov; 25(9):541-4. PubMed ID: 7453494 [No Abstract] [Full Text] [Related]
14. [Importance of the use of the beta-morpholino-ethylic ester of niflumic acid in the treatment of non-surgical ORL infections in children. Apropos of 21 cases]. Lauwers JP Rev Laryngol Otol Rhinol (Bord); 1979; 100(7-8):509-12. PubMed ID: 531386 [No Abstract] [Full Text] [Related]
15. [Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone]. Tarantino V; Stura M; Cremonesi G Minerva Pediatr; 1985 Oct; 37(20):827-32. PubMed ID: 3912657 [No Abstract] [Full Text] [Related]
16. [Action of Nifluril in otorhinolaryngologic practice]. Appaix A Rev Laryngol Otol Rhinol (Bord); 1971; 92(5):365-70. PubMed ID: 5568496 [No Abstract] [Full Text] [Related]
17. [A new anti-inflammatory agent: niflumic acid]. Warembourg H; Ducloux G Lille Med; 1969 Mar; ():Suppl 2:241-7. PubMed ID: 5402240 [No Abstract] [Full Text] [Related]
19. [Actol in the treatment of rheumatic diseases]. Furmaniuk M; Zimmermann-Górska I Reumatologia; 1974; 12(1):91-4. PubMed ID: 4546222 [No Abstract] [Full Text] [Related]
20. [Controlled clinical and experimental researches on the niflumic acid action in odontostomatology]. De Fazio M; De Fazio A Minerva Stomatol; 1972; 21(4):164-72. PubMed ID: 4570158 [No Abstract] [Full Text] [Related] [Next] [New Search]